Tangible Shareholders Equity: The value shareholders equity less intangible assets.
MBX Biosciences, Inc. (MBX) had Tangible Shareholders Equity of $409.54M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-37.09M |
|
-- |
|
-- |
|
$40.93M |
|
$-40.93M |
|
$3.84M |
|
$-37.09M |
|
$-37.09M |
|
$-37.09M |
|
$-37.09M |
|
$-37.09M |
|
$-37.09M |
|
$-40.93M |
|
$-40.85M |
|
47.70M |
|
47.70M |
|
$-0.78 |
|
$-0.78 |
|
| Balance Sheet Financials | |
$427.86M |
|
$4.66M |
|
$8.05M |
|
$435.91M |
|
$23.66M |
|
-- |
|
$2.71M |
|
$26.37M |
|
$409.54M |
|
|
Tangible Shareholders Equity |
$409.54M |
$409.54M |
|
47.95M |
|
| Cash Flow Statement Financials | |
$-42.83M |
|
$-67.89M |
|
$89.76M |
|
$75.29M |
|
$54.33M |
|
$-20.96M |
|
$11.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.06% |
|
-9.06% |
|
-8.51% |
|
-9.06% |
|
$8.54 |
|
$-0.93 |
|
$-0.90 |
|